(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

Deallus was the fourth acquisition made by GlobalData during the second half of its financial year, in addition to Business Trade Media International, LinkUp and Celent, as part of its ongoing growth ...

(Alliance News) - Team Internet Group PLC on Tuesday said it has received two takeover approaches, which it is considering with advisers. The London-based internet services company said the proposals ...

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Specifically, the group said it expects to post USD24.6 million in revenue, which would represent a 9.8% growth from GBP22.3 million last year. It expects annual Ebitda in the range of USD2.1 million ...

The company reported that production at the Triton FPSO resumed on December 27, with the export gas compressor successfully restarted and gas exports beginning on December 29. Serica expects that ...

(Alliance News) - Mirriad Advertising PLC on Tuesday announced a decline in revenue amid job cuts across the US media industry. The London-based virtual product placement and in-content advertising ...

Nichols will join Coats as CFO on April 24 and assume full responsibilities after its annual general meeting on May 21, succeeding Jackie Callaway, who has mutually agreed with the board of Coats to ...

(Alliance News) - Journeo PLC on Tuesday said it has won a GBP1.4 million contract with Stoke-on-Trent City Council for the supply and support of real-time passenger information technology.

(Alliance News) - Close Brothers Group PLC on Tuesday reported that Group Finance Director Mike Morgan will succeed Adrian Sainsbury as chief executive officer, effective from Monday.

Exane BNP cuts Mondi to 'neutral' (outperform) - price target 1,250 (1,430) pence Morgan Stanley raises Shell to 'overweight' (equal weight) - price target 3,070 (2,560) pence Kepler Cheuvreux starts ...

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer.